Home/Filings/4/0000899243-20-014288
4//SEC Filing

Mento Steven J 4

Accession 0000899243-20-014288

CIK 0001383701other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 6:04 AM ET

Size

10.0 KB

Accession

0000899243-20-014288

Insider Transaction Report

Form 4
Period: 2020-05-22
Mento Steven J
DirectorPresident, CEO & Director
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2020-05-2265,0000 total
    Common Stock (65,000 underlying)
  • Tax Payment

    Common Stock

    2020-05-22$0.56/sh31,428$17,60039,572 total
  • Exercise/Conversion

    Common Stock

    2020-05-22+65,00071,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    42,708
Footnotes (3)
  • [F1]Held by a family trust of which Dr. Mento is a trustee.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]Pursuant to the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among Conatus Pharmaceuticals Inc. ("Conatus"), Chinook Merger Sub, Inc. and Histogen Inc., all outstanding Conatus restricted stock units vested in full and were settled in shares of common stock prior to the closing of the merger contemplated by the Merger Agreement.

Issuer

Histogen Inc.

CIK 0001383701

Entity typeother

Related Parties

1
  • filerCIK 0001324466

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:04 AM ET
Size
10.0 KB